Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already mark the tool read-only and idempotent, and the description adds substantial behavioral detail beyond that: it cascades through multiple lookup endpoints, degrades gracefully when GLEIF or OpenFIGI is unavailable, returns ambiguous candidates via figi_candidates rather than asserting a match, and explicitly reports unresolved identifiers under unresolved. This gives the agent a clear model of both success and failure behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is structured with clear trigger examples, a stated usage rule, and supported-type sections. Nearly every clause adds useful context, though some details in the parentheticals could be tightened or moved to the schema without loss.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the responsibility of explaining expected results. It covers return behavior thoroughly: identifiers are labelled with their source, unresolved identifiers appear under unresolved, ambiguous matches return figi_candidates, drug results include RxCUI and brand/ingredient, and enrichment degradation is disclosed. This is sufficient for an agent to know what the tool will do and what it will receive.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema already describes both parameters well and even includes formatting caveats for the value parameter, so the baseline is high. The description adds meaningful extras, such as accepting ISIN as an input form and explaining that an ISIN resolves to the legal entity that issued the security, which goes beyond the schema. However, the schema already carries much of the semantic burden, so this is strong but not exceptional.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language triggers and a specific purpose: resolving a user-spoken name to the canonical/official identifiers other tools require as input. It further differentiates itself by enumerating supported entity types and by positioning itself as a first-step lookup ('Use FIRST whenever you have a name but need an ID') that replaces multiple manual lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit when-to-use guidance ('Use FIRST whenever you have a name but need an ID') and provides example user queries such as 'what's the ticker for...' and 'find the CIK for...'. It scopes supported types and inputs, but it does not name alternative sibling tools or explicitly state when NOT to use this tool, leaving the comparison to alternatives only implicit.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes: ask_pipeworx and ask_pipeworx_beta are currently identical, ask_pipeworx_grounded and validate_claim both perform claim verification, and polymarket_edges and polymarket_arbitrage both surface trading opportunities. While descriptions are detailed, the boundaries are fuzzy and agents could easily select the wrong tool.

Naming Consistency3/5

Naming mixes verb-first (search, subscribe, recall, validate_claim) with noun-first (dataset, facets, recent, entity_profile) conventions, and some names are just adjectives or nouns. Consistent prefixed groups exist (polymarket_*, ask_pipeworx_*), but the overall style is inconsistent and the server name 'Pangaea' doesn't align with the dominant 'pipeworx' prefix.

Tool Count2/5

36 tools is excessive for a coherent set, especially given the server bundles unrelated domains (earth science, general data research, prediction markets, memory, utilities). Several tools are redundant (e.g., ask_pipeworx_beta duplicates ask_pipeworx), and many are niche (ai_visibility_check, generate_llms_txt, scan_dependency) that don't fit the apparent primary purpose.

Completeness3/5

The PANGAEA dataset surface covers search, retrieval by ID/DOI, recent, and facets, but lacks export or citation tools. The Pipeworx research tools are broad, but prediction market access has no simple market-price query (only analysis-oriented tools), and there are notable gaps in lifecycle coverage for some subdomains.